Chemed Corp (CHE)
NYSE
Key stats Fiscal year 2025
Income statement
- Revenue
- 2,529,978,000 4.1%
- Net income
- 265,238,000 -12.2%
- Operating income
- 338,246,000
- Earnings per share
- 18.42 -8.4%
Growth and profitability
- Operating margin
- 13.37
- Net margin
- 10.48
- Return on equity
- 27.08
- Return on assets
- 17.24
- Free cash flow margin
- 12.86
Balance sheet
- Total assets
- 1,538,189,000
- Total liabilities
- 558,784,000
- Shareholders' equity
- 979,405,000
- Cash and equivalents
- 74,515,000
- Current ratio
- 1.05
Cash flow and ratios
- Operating cash flow
- 388,272,000
- Free cash flow
- 325,477,000
- Interest coverage
- 193.28
Shareholder returns
- Dividends paid
- 31,695,000
- Share buybacks
- 431,500,000
- Shares outstanding
- 13,014,915
- Book value per share
- 75.25
Company information
- Headquarters
- Cincinnati, OH
- Exchange
- NYSE
- Fiscal year end
- 12-31
- Industry (SEC)
- Services-Home Health Care Services
Fiscal year end: · Source: SEC EDGAR
Chemed Corp trades on NYSE under the ticker symbol CHE. This page brings together its price chart, company profile, key financial figures and technical indicators.